// App-Quantinova.ai

402P : CIRCULATING TUMOR CELLS ANALYSED BY SCANNING FLUORESCENCE MICROSCOPY IN THE XENA TRIAL

Researchers

Presenter

  • T. Hillig

Principal Investigators

  • A. Nygaard

  • A.S. Brems-Eskildsen

  • S.T.T. Langkjer

  • G. Soletormos

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

Biomarkers

  • Circulating tumor cells

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Vinorelbine

  • Capecitabine

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved